Payoneer Global Inc. (PAYO)
Whether directors and officers of Payoneer Global Inc. (PAYO) breached their fiduciary duties to the company and its shareholders.
Investigation
05/12/2022
Resolution
06/03/2022
This is a confidential investigation of whether certain directors & officers of Gevo, Inc. (GEVO) breached their fiduciary duties to Gevo and its shareholders.
Gevo investors and shareholders are encouraged to contact the law firm below for additional information.
04/20/2022
Gevo, Inc. files its proxy materials with the SEC for its 2022 annual meeting to be held on Thursday, June 1, 2022.
“The Annual Meeting will be held for the following purposes:
1. To elect two Class III directors to our Board of Directors to serve until the 2025 Annual Meeting of Stockholders;
2. To ratify the appointment of Grant Thornton LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2022; and
3. To transact such other business as may properly come before the Annual Meeting and any adjournment or postponement thereof.”
See more on Factual Timeline
We have marked this investigation as closed.
The stockholders annual meeting took place.
On 06/03/2022 the company issued the following statement:
Item 5.07. Submission of Matters to a Vote of Security Holders.Gevo, Inc. (the “Company”) held its 2022 Annual Meeting of Stockholders on June 1, 2022 via live online audio webcast (the “Annual Meeting”). At the Annual Meeting, the Company’s stockholders voted on two proposals, each of which is described in more detail in the Company’s definitive proxy statement on Schedule 14A filed with the U.S. Securities and Exchange Commission on April 20, 2022. Stockholders approved each of the proposals presented for a vote. The tables below set forth the number of votes cast for and against or withheld, and the number of abstentions or broker non-votes, for each matter voted upon by the Company’s stockholders.
Whether directors and officers of Payoneer Global Inc. (PAYO) breached their fiduciary duties to the company and its shareholders.
Whether directors and officers of Inari Medical, Inc. (NARI) breached their fiduciary duties to the company and its shareholders.
Whether directors and officers of LegalZoom.com, Inc. (LZ) breached their fiduciary duties to the company and its shareholders.
Confidential investigation: officers & directors’ potential breach of fiduciary duties to investors.
Whether directors and officers of Kewaunee Scientific Corporation (KEQU) breached their fiduciary duties to the company and its shareholders.
Whether directors and officers of Amicus Therapeutics, Inc. (FOLD) breached their fiduciary duties to the company and its shareholders.